Dose Errors After Hours: What the Evidence Shows

Every hospital pharmacy director has heard some version of the claim: after-hours is when things go wrong. The argument is intuitive. Reduced staffing, fatigued providers, fewer checks in place. But intuition is not evidence, and the evidence on after-hours medication errors is more specific, and more instructive, than the general claim suggests.

This article reviews what the peer-reviewed literature actually documents about medication error patterns in the after-hours window, what types of errors telepharmacy services consistently intercept, and what the coverage model means for clinical quality outcomes.

The Gap Is Structural, Not Incidental

Before examining error rates, it is worth being precise about what "after-hours pharmacy coverage" means in practice. For most Critical Access Hospitals and small rural facilities, overnight pharmacy coverage falls into one of three categories: on-call pharmacist (remote, phone-only), no pharmacist on duty with nurse-override protocols active, or telepharmacy services providing real-time order verification by a board-certified pharmacist.

The American Society of Health-System Pharmacists (ASHP) Statement on Telehealth Pharmacy Practice identifies the coverage gap in small and rural hospitals as a primary driver of telepharmacy adoption, noting that remote medication order review by pharmacists is a direct response to the inability of these facilities to staff overnight pharmacy coverage with on-site pharmacists [ASHP, 2021].

The distinction between nurse-override and pharmacist-verified orders matters clinically. When nurse-override protocols are the only backstop during the overnight window, the pharmacist safety check that would otherwise catch transcription errors, dose-weight mismatches, renal dosing contraindications, and duplicate therapy is removed from the workflow entirely. The order goes directly from provider to dispense.

What Telepharmacy Actually Catches: The North Dakota Data

The most detailed peer-reviewed dataset on medication quality-related events (QREs) in Critical Access Hospitals using telepharmacy comes from the North Dakota Telepharmacy Project, published in the American Journal of Health-System Pharmacy [Scott, Friesner, Rathke, and Doherty-Johnsen, 2014].

The study analyzed 17-months of medication order data across 17 rural CAHs, covering cumulative monthly order volumes ranging from 12,535 to 18,257. Remote pharmacists reviewed orders, identified QREs, and coded clinical interventions.

The findings are instructive:

• Clinical intervention rates ranged from 1.3% to 3.1% of all medication orders reviewed.
• Visual medication verification flags (catching preparation or labeling errors before dispense) occurred in 8.0% to 14.2% of orders.
• Transcription errors were the most frequently identified QRE category, accounting for 2,389 interventions, or 43.3% of all events.
• Prescribing-related QREs accounted for an additional 2,078 interventions, or 37.7%.

"Transcription errors accounted for 43.3% of all quality-related events identified by remote pharmacists across 17 critical access hospitals, with prescribing errors comprising an additional 37.7%." [Scott et al., AJHP, 2014]

The clinical significance of these interventions is not limited to clerical corrections. The study documented 547 dosage adjustment interventions, 437 DVT prophylaxis interventions, 268 pharmacokinetic consultations, 182 renal dosing corrections, 148 minor adverse drug event preventions, and 94 major adverse drug event preventions.

Major adverse drug event prevention is the category that carries the heaviest patient safety weight. The data does not tell us how many of those 94 events would have caused patient harm if not intercepted, but the clinical literature is consistent in its finding that major ADEs result in longer length of stay, increased cost, and elevated mortality risk.

The Error Types Most Concentrated in Low-Oversight Periods

The North Dakota data reflects all-hours order review, not specifically overnight. But the error types documented, particularly transcription errors and renal dosing failures, are structurally associated with the conditions that define after-hours clinical environments: higher order volumes relative to staff, less time for provider double-checking, and reduced access to clinical pharmacy consultation.

Renal dosing errors are a useful example. Appropriate renal dosing requires access to current lab values, familiarity with the patient's medication history, and a pharmacist who can calculate dose adjustments against creatinine clearance in real time. A provider writing orders at 2 AM in a rural emergency department, without an available pharmacist, is working without one of those three inputs. The North Dakota data showed 182 renal dosing corrections across the study period, each representing an order that reached a pharmacist review step and was caught before dispense.

The same logic applies to DVT prophylaxis. The 437 interventions in that category are not medication errors in the traditional sense. They are clinical gap identifications: patients who were at risk and for whom prophylaxis had not been ordered. This type of intervention requires a clinical pharmacist who is embedded in the patient record, not simply processing orders in a queue.

Coverage Hours Versus Coverage Depth

One persistent misconception in how telepharmacy is evaluated is the assumption that coverage hours are the primary variable. In this framing, the question is simply: is a pharmacist available during a given window? The answer is treated as binary.

The error data suggests that coverage depth, meaning what the pharmacist has access to and how embedded they are in the clinical workflow, is equally important.

A phone-on-call model provides nominal after-hours pharmacist access. A provider can call with a question. But the pharmacist in that model is not reviewing orders in real time, does not have eyes on the medication administration record, and is not proactively catching the DVT prophylaxis gap or the renal dosing mismatch. Those errors proceed to dispense unless a provider happens to call about them, which is structurally unlikely because the provider may not know the error exists.

Telepharmacy services that provide active order verification, with full read access to the pharmacy information system and EHR, change the structure of the review. The pharmacist is not waiting for a question. They are working through the order queue, applying clinical judgment to each order, and documenting interventions. The North Dakota data captures that model, which is why the intervention counts are specific and granular rather than anecdotal.

This distinction matters when evaluating telepharmacy programs. The relevant question is not whether a pharmacist is technically reachable after hours. It is whether every medication order written after hours receives the same pharmacist review that orders written at 10 AM receive.

The NetlinkRx Position

NetlinkRx is designed to approach after-hours coverage from a clinical embedding premise rather than a coverage-hours premise. NetlinkRx is built so that pharmacists have complete read and verification access to the partner hospital's EHR, pharmacy information system, and clinical protocols before they take a single order. The model is designed so pharmacists are not reviewing orders as a remote queue. They function as an extension of the department, applying the same clinical depth to an order written at 3 AM as the on-site team would apply at noon.

The error types documented in the peer-reviewed literature, transcription errors, renal dosing failures, missed prophylaxis, dose-weight mismatches, are all intercepted at the order verification step. That step only functions as a safety filter when the pharmacist performing it has full clinical context. NetlinkRx is designed around that requirement.

References

1. American Society of Health-System Pharmacists. ASHP Statement on Telehealth Pharmacy Practice. American Journal of Health-System Pharmacy. 2022;79(19):1728. Link
2. Scott DM, Friesner DL, Rathke AM, Doherty-Johnsen S. Medication error reporting in rural critical access hospitals in the North Dakota Telepharmacy Project. American Journal of Health-System Pharmacy. 2014;71(1):58-67. Link

Want hospital telepharmacy insights every Tuesday? NetlinkRx publishes a weekly briefing for pharmacy leaders on operational ROI, clinical quality, regulatory shifts, and the future of the department. Direct, cited, no fluff. Subscribe at netlinkrx.com.